Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

Technology appraisal guidance
Reference number: TA209
Published: 24 November 2010

TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive

TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive

TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive
21 October 2013
(108.62 Kb 31 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 October 2013